Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$972.8K
42 trades · 8 insiders
Net · 90d
$-972.8K
Insiders on file
52
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Hohenleitner Susan | Chief Financial Officer | 7 | $0 | $33.0K | 2026-08-21 |
| Brady James Parker | Chief Human Resources Officer | 9 | $0 | $143.3K | 2026-08-21 |
| Reilly Joseph James | See Remarks | 12 | $0 | $144.7K | 2026-08-21 |
| Foster Eric Duane | Chief Commercial Officer | 22 | $0 | $310.5K | 2026-08-21 |
| Kelliher Mike | See Remarks | 21 | $0 | $283.6K | 2026-08-21 |
| Williams Laura A | See Remarks | 59 | $1.9K | $3.38M | 2026-08-21 |
| RAAB MICHAEL | President & CEO, Director | 158 | $1.9K | $9.02M | 2026-08-21 |
| Bishop John E | See Remarks | 10 | $0 | $185.5K | 2026-08-21 |
| Bhanji Muna | Director | 9 | $0 | $0 | 2026-06-16 |
| Cadoret-Manier Onaiza | Director | 12 | $0 | $0 | 2026-06-16 |
| Parsey Merdad | Director | 5 | $0 | $0 | 2026-06-16 |
| Bazemore Robert B | Director | 13 | $0 | $0 | 2026-06-16 |
| Rodgers Richard J | Director | 28 | $0 | $0 | 2026-06-16 |
| Bertrand William C JR | Director | 27 | $100.0K | $0 | 2026-06-16 |
| MOTT DAVID M | Director, 10% Owner | 54 | $65.16M | $0 | 2026-06-16 |
| GRAMMER ELIZABETH A | VP, General Counsel | 118 | $2.4K | $5.44M | 2025-11-21 |
| Renz Justin A | Chief Financial Officer | 42 | $1.9K | $1.80M | 2025-08-21 |
| Blanks Robert | See Remarks | 42 | $0 | $1.01M | 2024-11-20 |
| Rosenbaum David P. | SVP, Drug Development | 124 | $1.9K | $2.72M | 2024-11-20 |
| Felsch Robert Ora | See Remarks | 18 | $1.9K | $1.92M | 2024-08-20 |
| Rodriguez Susan | Chief Commercial Officer | 31 | $0 | $274.7K | 2024-05-21 |
| Block Geoffrey A. | Director | 5 | $0 | $0 | 2023-06-15 |
| Lundberg Jan M | Director | 12 | $0 | $0 | 2023-06-15 |
| BASKETT FOREST | 10% Owner | 52 | $85.18M | $4.40M | 2021-12-15 |
| SANDELL SCOTT D | 10% Owner | 52 | $85.18M | $4.25M | 2021-12-15 |
| Jacobs Jeffrey W | VP, Chemistry | 57 | $0 | $969.2K | 2021-11-22 |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | 6 | $31.74M | $0 | 2020-06-10 |
| NEA 12 GP, LLC | 10% Owner | 4 | $0 | $0 | 2020-06-10 |
| KERINS PATRICK J | 10% Owner | 30 | $38.89M | $0 | 2020-06-10 |
| RINGOLD GORDON | Director | 10 | $308.4K | $0 | 2020-06-09 |
| NEA 15 GP, LLC | 10% Owner | 7 | $23.33M | $0 | 2019-12-09 |
| Makhzoumi Mohamad | 10% Owner | 1 | $0 | $0 | 2019-12-09 |
| Florence Anthony A. Jr. | 10% Owner | 7 | $23.33M | $0 | 2019-12-09 |
| Sonsini Peter W. | 10% Owner | 7 | $23.33M | $0 | 2019-12-09 |
| MAKOWER JOSHUA | 10% Owner | 7 | $23.33M | $0 | 2019-12-09 |
| BARRIS PETER J | 10% Owner | 22 | $85.18M | $42.0K | 2019-12-09 |
| Kaufmann Mark | Chief Financial Officer | 29 | $0 | $472.0K | 2019-10-07 |
| Jenkins Annalisa | Director | 7 | $0 | $0 | 2019-06-13 |
| Sakoda Jon | 10% Owner | 6 | $23.33M | $0 | 2018-05-25 |
| Viswanathan Ravi | 10% Owner | 6 | $23.33M | $0 | 2018-05-25 |
| BARRETT M JAMES | 10% Owner | 12 | $31.74M | $54.7K | 2018-05-25 |
| Seeto Reginald | Chief Operating Officer | 8 | $0 | $52.0K | 2018-01-16 |
| Caldwell Jeremy S | EVP, Chief Scientific Officer | 11 | $0 | $58.9K | 2018-01-16 |
| Korner Paul | EVP, Chief Medical Officer | 5 | $0 | $79.4K | 2017-01-19 |
| Weller Harry R | 10% Owner | 4 | $23.33M | $0 | 2016-07-18 |
| KOLLURI KRISHNA KITTU | 10% Owner | 19 | $85.18M | $5.4K | 2016-07-18 |
| Arasaratnam Narani | VP, Corporate Controller | 3 | $0 | $0 | 2016-01-15 |
| Presidio Partners 2007, L.P. | 10% Owner | 22 | $4.44M | $0 | 2015-12-15 |
| SCHULTZ PETER G | Director | 12 | $501.8K | $0 | 2015-06-11 |
| DRANT RYAN D | 10% Owner | 5 | $20.07M | $0 | 2015-06-05 |
| JUE GEORGE | VP, Operations & Facilities | 2 | $0 | $23.8K | 2015-03-02 |
| CMEA VENTURES VII (PARALLEL) LP | 10% Owner | 6 | $0 | $11.93M | 2015-01-30 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| RAAB MICHAEL | President & CEO | S Sale | 2026-08-21 | 2026-08-25 | 8,411 | $3.86 | $32.5K | 1,638,970 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-08-21 | 2026-08-25 | 15,976 | $3.86 | $61.7K | 1,647,381 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-08-21 | 2026-08-25 | 19,178 | $3.86 | $74.0K | 1,619,792 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-08-21 | 2026-08-25 | 15,009 | $3.86 | $57.9K | 1,663,357 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2026-08-21 | 2026-08-25 | 3,089 | $3.86 | $11.9K | 371,620 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2026-08-21 | 2026-08-25 | 2,430 | $3.86 | $9.4K | 369,190 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2026-08-21 | 2026-08-25 | 1,734 | $3.86 | $6.7K | 367,456 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2026-08-21 | 2026-08-25 | 3,486 | $3.86 | $13.5K | 374,709 | SEC↗ |
| Kelliher Mike | Chief Business Officer | S Sale | 2026-08-21 | 2026-08-25 | 2,652 | $3.86 | $10.2K | 351,662 | SEC↗ |
| Kelliher Mike | Chief Business Officer | S Sale | 2026-08-21 | 2026-08-25 | 2,002 | $3.86 | $7.7K | 349,660 | SEC↗ |
| Kelliher Mike | Chief Business Officer | S Sale | 2026-08-21 | 2026-08-25 | 3,104 | $3.86 | $12.0K | 354,314 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | S Sale | 2026-08-21 | 2026-08-25 | 2,575 | $3.86 | $9.9K | 409,410 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | S Sale | 2026-08-21 | 2026-08-25 | 3,389 | $3.86 | $13.1K | 411,985 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | S Sale | 2026-08-21 | 2026-08-25 | 2,598 | $3.86 | $10.0K | 415,374 | SEC↗ |
| Brady James Parker | Chief Human Resources Office | S Sale | 2026-08-21 | 2026-08-25 | 1,976 | $3.86 | $7.6K | 259,090 | SEC↗ |
| Brady James Parker | Chief Human Resources Office | S Sale | 2026-08-21 | 2026-08-25 | 13,160 | $3.86 | $50.8K | 245,930 | SEC↗ |
| Bishop John E | See Remarks | S Sale | 2026-08-21 | 2026-08-25 | 2,469 | $3.86 | $9.5K | 317,095 | SEC↗ |
| Bishop John E | See Remarks | S Sale | 2026-08-21 | 2026-08-25 | 17,281 | $3.86 | $66.7K | 319,564 | SEC↗ |
| Reilly Joseph James | See Remarks | S Sale | 2026-08-21 | 2026-08-25 | 2,872 | $3.86 | $11.1K | 146,964 | SEC↗ |
| Reilly Joseph James | See Remarks | S Sale | 2026-08-21 | 2026-08-25 | 1,110 | $3.86 | $4.3K | 145,854 | SEC↗ |
| Hohenleitner Susan | Chief Financial Officer | S Sale | 2026-08-21 | 2026-08-25 | 1,558 | $3.86 | $6.0K | 227,520 | SEC↗ |
| Hohenleitner Susan | Chief Financial Officer | S Sale | 2026-08-21 | 2026-08-25 | 1,558 | $3.86 | $6.0K | 227,520 | SEC↗ |
| Brady James Parker | Chief Human Resources Office | S Sale | 2026-08-21 | 2026-08-25 | 13,160 | $3.86 | $50.8K | 245,930 | SEC↗ |
| Brady James Parker | Chief Human Resources Office | S Sale | 2026-08-21 | 2026-08-25 | 1,976 | $3.86 | $7.6K | 259,090 | SEC↗ |
| Reilly Joseph James | See Remarks | S Sale | 2026-08-21 | 2026-08-25 | 1,110 | $3.86 | $4.3K | 145,854 | SEC↗ |
| Reilly Joseph James | See Remarks | S Sale | 2026-08-21 | 2026-08-25 | 2,872 | $3.86 | $11.1K | 146,964 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | S Sale | 2026-08-21 | 2026-08-25 | 2,575 | $3.86 | $9.9K | 409,410 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | S Sale | 2026-08-21 | 2026-08-25 | 3,389 | $3.86 | $13.1K | 411,985 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | S Sale | 2026-08-21 | 2026-08-25 | 2,598 | $3.86 | $10.0K | 415,374 | SEC↗ |
| Kelliher Mike | Chief Business Officer | S Sale | 2026-08-21 | 2026-08-25 | 2,002 | $3.86 | $7.7K | 349,660 | SEC↗ |
| Kelliher Mike | Chief Business Officer | S Sale | 2026-08-21 | 2026-08-25 | 2,652 | $3.86 | $10.2K | 351,662 | SEC↗ |
| Kelliher Mike | Chief Business Officer | S Sale | 2026-08-21 | 2026-08-25 | 3,104 | $3.86 | $12.0K | 354,314 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2026-08-21 | 2026-08-25 | 1,734 | $3.86 | $6.7K | 367,456 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2026-08-21 | 2026-08-25 | 2,430 | $3.86 | $9.4K | 369,190 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2026-08-21 | 2026-08-25 | 3,089 | $3.86 | $11.9K | 371,620 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2026-08-21 | 2026-08-25 | 3,486 | $3.86 | $13.4K | 374,709 | SEC↗ |
| RAAB MICHAEL | President & CEO, Director | S Sale | 2026-08-21 | 2026-08-25 | 19,178 | $3.86 | $74.0K | 1,619,792 | SEC↗ |
| RAAB MICHAEL | President & CEO, Director | S Sale | 2026-08-21 | 2026-08-25 | 8,411 | $3.86 | $32.4K | 1,638,970 | SEC↗ |
| RAAB MICHAEL | President & CEO, Director | S Sale | 2026-08-21 | 2026-08-25 | 15,976 | $3.86 | $61.6K | 1,647,381 | SEC↗ |
| RAAB MICHAEL | President & CEO, Director | S Sale | 2026-08-21 | 2026-08-25 | 15,009 | $3.86 | $57.9K | 1,663,357 | SEC↗ |
| Bishop John E | See Remarks | S Sale | 2026-08-21 | 2026-08-25 | 2,469 | $3.86 | $9.5K | 317,095 | SEC↗ |
| Bishop John E | See Remarks | S Sale | 2026-08-21 | 2026-08-25 | 17,281 | $3.86 | $66.7K | 319,564 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise deriv | 2026-07-15 | 2026-07-17 | 20,834 | — | $0 | 290,834 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise | 2026-07-15 | 2026-07-17 | 20,834 | $0.99 | $20.6K | 1,720,034 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-07-15 | 2026-07-17 | 41,668 | $5.06 | $210.8K | 1,678,366 | SEC↗ |
| Williams Laura A | Chief Patient Officer | M Exercise deriv | 2026-06-18 | 2026-06-22 | 31,000 | — | $0 | 31,000 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2026-06-18 | 2026-06-22 | 81,898 | $5.99 | $490.6K | 378,195 | SEC↗ |
| Williams Laura A | Chief Patient Officer | M Exercise | 2026-06-18 | 2026-06-22 | 31,000 | $0.99 | $30.7K | 460,093 | SEC↗ |
| Bazemore Robert B | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 39,715 | — | $0 | 39,715 | SEC↗ |
| Bertrand William C JR | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 39,715 | — | $0 | 39,715 | SEC↗ |
| Bhanji Muna | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 39,715 | — | $0 | 39,715 | SEC↗ |
| Cadoret-Manier Onaiza | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 39,715 | — | $0 | 39,715 | SEC↗ |
| MOTT DAVID M | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 39,715 | — | $0 | 39,715 | SEC↗ |
| Rodgers Richard J | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 39,715 | — | $0 | 39,715 | SEC↗ |
| Parsey Merdad | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 39,715 | — | $0 | 39,715 | SEC↗ |
| Bazemore Robert B | Director | A Award | 2026-06-16 | 2026-06-18 | 26,455 | — | $0 | 68,006 | SEC↗ |
| Bertrand William C JR | Director | A Award | 2026-06-16 | 2026-06-18 | 12,345 | — | $0 | 303,052 | SEC↗ |
| Bertrand William C JR | Director | A Award | 2026-06-16 | 2026-06-18 | 26,455 | — | $0 | 329,507 | SEC↗ |
| Bhanji Muna | Director | A Award | 2026-06-16 | 2026-06-18 | 26,455 | — | $0 | 163,808 | SEC↗ |
| Cadoret-Manier Onaiza | Director | A Award | 2026-06-16 | 2026-06-18 | 26,455 | — | $0 | 178,156 | SEC↗ |
| MOTT DAVID M | Director | A Award | 2026-06-16 | 2026-06-18 | 20,282 | — | $0 | 3,323,200 | SEC↗ |
| MOTT DAVID M | Director | A Award | 2026-06-16 | 2026-06-18 | 26,455 | — | $0 | 3,349,655 | SEC↗ |
| Rodgers Richard J | Director | A Award | 2026-06-16 | 2026-06-18 | 26,455 | — | $0 | 439,998 | SEC↗ |
| Parsey Merdad | Director | A Award | 2026-06-16 | 2026-06-18 | 26,455 | — | $0 | 83,746 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise deriv | 2026-06-15 | 2026-06-17 | 20,833 | — | $0 | 311,668 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-06-15 | 2026-06-17 | 41,666 | $5.67 | $236.2K | 1,699,200 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise | 2026-06-15 | 2026-06-17 | 20,833 | $0.99 | $20.6K | 1,740,866 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-05-21 | 2026-05-22 | 14,933 | $6.27 | $93.6K | 1,759,848 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-05-21 | 2026-05-22 | 7,861 | $6.27 | $49.3K | 1,751,987 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-05-21 | 2026-05-22 | 17,926 | $6.27 | $112.4K | 1,734,061 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-05-21 | 2026-05-22 | 14,028 | $6.27 | $88.0K | 1,720,033 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2026-05-21 | 2026-05-22 | 2,157 | $6.27 | $13.5K | 432,422 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2026-05-21 | 2026-05-22 | 1,503 | $6.27 | $9.4K | 434,579 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2026-05-21 | 2026-05-22 | 1,911 | $6.27 | $12.0K | 430,511 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2026-05-21 | 2026-05-22 | 1,418 | $6.27 | $8.9K | 429,093 | SEC↗ |
| Kelliher Mike | Chief Business Officer | S Sale | 2026-05-21 | 2026-05-22 | 2,478 | $6.27 | $15.5K | 357,418 | SEC↗ |
| Kelliher Mike | Chief Business Officer | S Sale | 2026-05-21 | 2026-05-22 | 1,870 | $6.27 | $11.7K | 359,896 | SEC↗ |
| Kelliher Mike | Chief Business Officer | S Sale | 2026-05-21 | 2026-05-22 | 2,900 | $6.27 | $18.2K | 361,766 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | S Sale | 2026-05-21 | 2026-05-22 | 2,405 | $6.27 | $15.1K | 417,972 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | S Sale | 2026-05-21 | 2026-05-22 | 3,166 | $6.27 | $19.9K | 422,804 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | S Sale | 2026-05-21 | 2026-05-22 | 2,427 | $6.27 | $15.2K | 420,377 | SEC↗ |
| Brady James Parker | Chief Human Resources Office | S Sale | 2026-05-21 | 2026-05-22 | 1,846 | $6.27 | $11.6K | 261,066 | SEC↗ |
| Bishop John E | See Remarks | S Sale | 2026-05-21 | 2026-05-22 | 2,306 | $6.27 | $14.5K | 336,845 | SEC↗ |
| Hohenleitner Susan | Chief Financial Officer | S Sale | 2026-05-21 | 2026-05-22 | 1,455 | $6.27 | $9.1K | 229,078 | SEC↗ |
| Reilly Joseph James | See Remarks | S Sale | 2026-05-21 | 2026-05-22 | 1,036 | $6.27 | $6.5K | 149,836 | SEC↗ |
| Reilly Joseph James | See Remarks | S Sale | 2026-05-21 | 2026-05-22 | 2,683 | $6.27 | $16.8K | 149,107 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise deriv | 2026-05-15 | 2026-05-19 | 20,833 | — | $0 | 332,501 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise | 2026-05-15 | 2026-05-19 | 20,833 | $0.99 | $20.6K | 1,816,447 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-05-15 | 2026-05-19 | 41,666 | $6.28 | $261.7K | 1,774,781 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise deriv | 2026-04-15 | 2026-04-17 | 20,834 | — | $0 | 353,334 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-04-15 | 2026-04-17 | 41,668 | $6.29 | $262.1K | 1,795,614 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise | 2026-04-15 | 2026-04-17 | 20,834 | $0.99 | $20.6K | 1,837,282 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise deriv | 2026-03-16 | 2026-03-18 | 20,833 | — | $0 | 374,168 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise | 2026-03-16 | 2026-03-18 | 20,833 | $0.99 | $20.6K | 1,856,986 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-03-16 | 2026-03-18 | 41,666 | $5.84 | $243.3K | 1,816,448 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise deriv | 2026-02-24 | 2026-02-25 | 20,833 | — | $0 | 395,001 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-02-24 | 2026-02-25 | 41,666 | $6.26 | $260.8K | 1,836,153 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise | 2026-02-24 | 2026-02-25 | 20,833 | $0.99 | $20.6K | 1,877,819 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | S Sale | 2026-02-20 | 2026-02-23 | 9,176 | $5.87 | $53.9K | 427,233 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | S Sale | 2026-02-20 | 2026-02-23 | 1 | $5.71 | $6 | 425,971 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | S Sale | 2026-02-20 | 2026-02-23 | 1 | $5.70 | $6 | 425,970 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | S Sale | 2026-02-20 | 2026-02-23 | 1,261 | $5.71 | $7.2K | 425,972 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-02-20 | 2026-02-23 | 1 | $5.70 | $6 | 1,856,988 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-02-20 | 2026-02-23 | 2 | $5.70 | $11 | 1,856,989 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-02-20 | 2026-02-23 | 5,576 | $5.71 | $31.8K | 1,856,991 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-02-20 | 2026-02-23 | 40,401 | $5.87 | $237.2K | 1,862,567 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2026-02-20 | 2026-02-23 | 2 | $5.70 | $11 | 1,856,986 | SEC↗ |
| Kelliher Mike | See Remarks | S Sale | 2026-02-20 | 2026-02-23 | 2 | $5.71 | $11 | 364,666 | SEC↗ |
| Kelliher Mike | See Remarks | S Sale | 2026-02-20 | 2026-02-23 | 1,159 | $5.71 | $6.6K | 364,668 | SEC↗ |
| Kelliher Mike | See Remarks | S Sale | 2026-02-20 | 2026-02-23 | 8,434 | $5.87 | $49.5K | 365,827 | SEC↗ |
| Brady James Parker | Chief Human Resources Office | S Sale | 2026-02-20 | 2026-02-23 | 309 | $5.71 | $1.8K | 262,912 | SEC↗ |
| Brady James Parker | Chief Human Resources Office | S Sale | 2026-02-20 | 2026-02-23 | 2,234 | $5.87 | $13.1K | 263,221 | SEC↗ |
| Hohenleitner Susan | Chief Financial Officer | S Sale | 2026-02-20 | 2026-02-23 | 247 | $5.71 | $1.4K | 230,533 | SEC↗ |
| Hohenleitner Susan | Chief Financial Officer | S Sale | 2026-02-20 | 2026-02-23 | 1,786 | $5.87 | $10.5K | 230,780 | SEC↗ |
| Williams Laura A | See Remarks | S Sale | 2026-02-20 | 2026-02-23 | 7,192 | $5.87 | $42.2K | 437,066 | SEC↗ |
| Williams Laura A | See Remarks | S Sale | 2026-02-20 | 2026-02-23 | 984 | $5.71 | $5.6K | 436,082 | SEC↗ |
| Reilly Joseph James | See Remarks | S Sale | 2026-02-20 | 2026-02-23 | 2 | $5.70 | $11 | 151,790 | SEC↗ |
| Reilly Joseph James | See Remarks | S Sale | 2026-02-20 | 2026-02-23 | 4,387 | $5.87 | $25.8K | 152,394 | SEC↗ |
| Reilly Joseph James | See Remarks | S Sale | 2026-02-20 | 2026-02-23 | 602 | $5.71 | $3.4K | 151,792 | SEC↗ |
| Bishop John E | See Remarks | S Sale | 2026-02-20 | 2026-02-23 | 386 | $5.71 | $2.2K | 339,152 | SEC↗ |
| Bishop John E | See Remarks | S Sale | 2026-02-20 | 2026-02-23 | 1 | $5.70 | $6 | 339,151 | SEC↗ |
| Bishop John E | See Remarks | S Sale | 2026-02-20 | 2026-02-23 | 2,792 | $5.87 | $16.4K | 339,538 | SEC↗ |
| MOTT DAVID M | Director | P Buy | 2026-02-20 | 2026-02-23 | 333,333 | $5.84 | $1.95M | 3,302,918 | SEC↗ |
| Bishop John E | See Remarks | A Award deriv | 2026-01-23 | 2026-01-26 | 186,500 | — | $0 | 186,500 | SEC↗ |
| Williams Laura A | Chief Patient Officer | A Award deriv | 2026-01-23 | 2026-01-26 | 124,040 | — | $0 | 124,040 | SEC↗ |
| Brady James Parker | Chief Human Resources Office | A Award deriv | 2026-01-23 | 2026-01-26 | 149,185 | — | $0 | 149,185 | SEC↗ |
| RAAB MICHAEL | President & CEO | A Award deriv | 2026-01-23 | 2026-01-26 | 669,330 | — | $0 | 669,330 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | A Award deriv | 2026-01-23 | 2026-01-26 | 206,915 | — | $0 | 206,915 | SEC↗ |
| Hohenleitner Susan | Chief Financial Officer | A Award deriv | 2026-01-23 | 2026-01-26 | 128,505 | — | $0 | 128,505 | SEC↗ |
| Kelliher Mike | See Remarks | A Award deriv | 2026-01-23 | 2026-01-26 | 154,625 | — | $0 | 154,625 | SEC↗ |
| Reilly Joseph James | See Remarks | A Award deriv | 2026-01-23 | 2026-01-27 | 69,360 | — | $0 | 69,360 | SEC↗ |
| Bishop John E | See Remarks | A Award | 2026-01-23 | 2026-01-26 | 124,330 | — | $0 | 342,330 | SEC↗ |
| Williams Laura A | Chief Patient Officer | A Award | 2026-01-23 | 2026-01-26 | 82,695 | — | $0 | 444,258 | SEC↗ |
| Brady James Parker | Chief Human Resources Office | A Award | 2026-01-23 | 2026-01-26 | 99,455 | — | $0 | 265,455 | SEC↗ |
| RAAB MICHAEL | President & CEO | A Award | 2026-01-23 | 2026-01-26 | 446,220 | — | $0 | 1,902,968 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | A Award | 2026-01-23 | 2026-01-26 | 137,945 | — | $0 | 436,409 | SEC↗ |
| Hohenleitner Susan | Chief Financial Officer | A Award | 2026-01-23 | 2026-01-26 | 85,670 | — | $0 | 232,566 | SEC↗ |
| Kelliher Mike | See Remarks | A Award | 2026-01-23 | 2026-01-26 | 103,080 | — | $0 | 374,261 | SEC↗ |
| Reilly Joseph James | See Remarks | A Award | 2026-01-23 | 2026-01-27 | 46,200 | — | $0 | 156,781 | SEC↗ |
| Williams Laura A | Chief Patient Officer | M Exercise deriv | 2026-01-08 | 2026-01-09 | 0 | — | $0 | 62,000 | SEC↗ |
| Williams Laura A | Chief Patient Officer | M Exercise | 2026-01-08 | 2026-01-09 | 50,000 | $0.99 | $49.5K | 409,896 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2026-01-08 | 2026-01-09 | 50,000 | $6.98 | $349.0K | 361,563 | SEC↗ |
| Reilly Joseph James | See Remarks | S Sale | 2025-11-21 | 2025-11-25 | 11,086 | $5.54 | $61.4K | 108,914 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | S Sale | 2025-11-21 | 2025-11-25 | 5,814 | $5.54 | $32.2K | 295,684 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2025-11-21 | 2025-11-25 | 6,426 | $5.54 | $35.6K | 359,896 | SEC↗ |
| Kelliher Mike | See Remarks | S Sale | 2025-11-21 | 2025-11-25 | 5,560 | $5.54 | $30.8K | 271,181 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2025-11-21 | 2025-11-25 | 46,887 | $5.54 | $259.8K | 1,455,363 | SEC↗ |
| GRAMMER ELIZABETH A | See Remarks | S Sale | 2025-11-21 | 2025-11-25 | 5,995 | $5.54 | $33.2K | 299,895 | SEC↗ |
| Williams Laura A | Chief Patient Officer | M Exercise deriv | 2025-08-26 | 2025-08-28 | 50,000 | — | $0 | 112,000 | SEC↗ |
| Williams Laura A | Chief Patient Officer | M Exercise | 2025-08-26 | 2025-08-28 | 50,000 | $0.99 | $49.5K | 446,322 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2025-08-26 | 2025-08-28 | 30,000 | $6.12 | $183.6K | 366,322 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2025-08-26 | 2025-08-28 | 50,000 | $6.12 | $306.0K | 396,322 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | S Sale | 2025-08-21 | 2025-08-25 | 15,308 | $5.93 | $90.8K | 301,498 | SEC↗ |
| GRAMMER ELIZABETH A | See Remarks | S Sale | 2025-08-21 | 2025-08-25 | 5,841 | $5.93 | $34.6K | 305,890 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2025-08-21 | 2025-08-25 | 45,687 | $5.93 | $270.9K | 1,502,250 | SEC↗ |
| Renz Justin A | Chief Financial Officer | S Sale | 2025-08-21 | 2025-08-25 | 7,037 | $5.93 | $41.7K | 409,052 | SEC↗ |
| Williams Laura A | Chief Patient Officer | S Sale | 2025-08-21 | 2025-08-25 | 6,261 | $5.93 | $37.1K | 396,322 | SEC↗ |
| Kelliher Mike | Chief Business Officer | S Sale | 2025-08-21 | 2025-08-28 | 5,417 | $5.93 | $32.1K | 276,741 | SEC↗ |
| Bertrand William C JR | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 54,059 | — | $0 | 54,059 | SEC↗ |
| Bhanji Muna | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 54,059 | — | $0 | 54,059 | SEC↗ |
| Cadoret-Manier Onaiza | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 54,059 | — | $0 | 54,059 | SEC↗ |
| MOTT DAVID M | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 54,059 | — | $0 | 54,059 | SEC↗ |
| Rodgers Richard J | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 54,059 | — | $0 | 54,059 | SEC↗ |
| Bazemore Robert B | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 54,059 | — | $0 | 54,059 | SEC↗ |
| Bertrand William C JR | Director | A Award | 2025-06-18 | 2025-06-23 | 41,551 | — | $0 | 290,707 | SEC↗ |
| Bertrand William C JR | Director | A Award | 2025-06-18 | 2025-06-23 | 19,390 | — | $0 | 249,156 | SEC↗ |
| Bhanji Muna | Director | A Award | 2025-06-18 | 2025-06-23 | 41,551 | — | $0 | 137,353 | SEC↗ |
| Cadoret-Manier Onaiza | Director | A Award | 2025-06-18 | 2025-06-23 | 41,551 | — | $0 | 151,701 | SEC↗ |
| MOTT DAVID M | Director | A Award | 2025-06-18 | 2025-06-23 | 41,551 | — | $0 | 2,969,585 | SEC↗ |
| MOTT DAVID M | Director | A Award | 2025-06-18 | 2025-06-23 | 31,163 | — | $0 | 2,928,034 | SEC↗ |
| Parsey Merdad | Director | A Award | 2025-06-18 | 2025-06-23 | 15,235 | — | $0 | 57,291 | SEC↗ |
| Rodgers Richard J | Director | A Award | 2025-06-18 | 2025-06-23 | 21,468 | — | $0 | 371,992 | SEC↗ |
| Rodgers Richard J | Director | A Award | 2025-06-18 | 2025-06-23 | 41,551 | — | $0 | 413,543 | SEC↗ |
| Bazemore Robert B | Director | A Award | 2025-06-18 | 2025-06-23 | 41,551 | — | $0 | 41,551 | SEC↗ |
| MOTT DAVID M | Director | P Buy | 2025-06-16 | 2025-06-18 | 200,000 | $3.63 | $726.0K | 2,896,871 | SEC↗ |
| MOTT DAVID M | Director | P Buy | 2025-06-09 | 2025-06-11 | 200,000 | $3.69 | $738.0K | 2,696,871 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | S Sale | 2025-05-20 | 2025-05-22 | 2,507 | $4.08 | $10.2K | 316,806 | SEC↗ |
| GRAMMER ELIZABETH A | See Remarks | S Sale | 2025-05-20 | 2025-05-22 | 5,992 | $4.08 | $24.4K | 311,731 | SEC↗ |
| Kelliher Mike | See Remarks | S Sale | 2025-05-20 | 2025-05-22 | 14,522 | $4.08 | $59.2K | 282,158 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2025-05-20 | 2025-05-22 | 46,817 | $4.08 | $191.0K | 1,547,937 | SEC↗ |
| Renz Justin A | Chief Financial Officer | S Sale | 2025-05-20 | 2025-05-22 | 7,218 | $4.08 | $29.4K | 416,089 | SEC↗ |
| Williams Laura A | Chief Medical Officer | S Sale | 2025-05-20 | 2025-05-22 | 6,421 | $4.08 | $26.2K | 402,583 | SEC↗ |
| MOTT DAVID M | Director | P Buy | 2025-05-15 | 2025-05-19 | 100,000 | $3.29 | $329.0K | 2,496,871 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise deriv | 2025-05-02 | 2025-05-05 | 20,833 | — | $0 | 415,834 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2025-05-02 | 2025-05-05 | 41,666 | $4.25 | $177.1K | 1,594,754 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise | 2025-05-02 | 2025-05-05 | 20,833 | $0.99 | $20.6K | 1,636,420 | SEC↗ |
| MOTT DAVID M | Director | P Buy | 2025-05-02 | 2025-05-05 | 381,377 | $4.22 | $1.61M | 2,396,871 | SEC↗ |
| Parsey Merdad | Director | A Award deriv | 2025-04-28 | 2025-05-14 | 64,457 | — | $0 | 64,457 | SEC↗ |
| Parsey Merdad | Director | A Award | 2025-04-28 | 2025-05-14 | 42,056 | — | $0 | 42,056 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise deriv | 2025-04-04 | 2025-04-08 | 20,833 | — | $0 | 436,667 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise | 2025-04-04 | 2025-04-08 | 20,833 | $0.99 | $20.6K | 1,657,253 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2025-04-04 | 2025-04-08 | 41,666 | $4.59 | $191.2K | 1,615,587 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise deriv | 2025-03-07 | 2025-03-07 | 20,834 | — | $0 | 457,500 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise | 2025-03-07 | 2025-03-07 | 20,834 | $0.99 | $20.6K | 1,676,806 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2025-03-07 | 2025-03-07 | 41,668 | $5.36 | $223.3K | 1,635,138 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | A Award deriv | 2025-02-25 | 2025-02-27 | 205,019 | — | $0 | 205,019 | SEC↗ |
| GRAMMER ELIZABETH A | See Remarks | A Award deriv | 2025-02-25 | 2025-02-27 | 205,019 | — | $0 | 205,019 | SEC↗ |
| Kelliher Mike | See Remarks | A Award deriv | 2025-02-25 | 2025-02-27 | 205,019 | — | $0 | 205,019 | SEC↗ |
| RAAB MICHAEL | President & CEO | A Award deriv | 2025-02-25 | 2025-02-27 | 855,326 | — | $0 | 855,326 | SEC↗ |
| Renz Justin A | Chief Financial Officer | A Award deriv | 2025-02-25 | 2025-02-27 | 205,019 | — | $0 | 205,019 | SEC↗ |
| Williams Laura A | Chief Medical Officer | A Award deriv | 2025-02-25 | 2025-02-27 | 157,700 | — | $0 | 157,700 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | A Award | 2025-02-25 | 2025-02-27 | 136,680 | — | $0 | 316,680 | SEC↗ |
| GRAMMER ELIZABETH A | See Remarks | A Award | 2025-02-25 | 2025-02-27 | 136,680 | — | $0 | 317,723 | SEC↗ |
| Kelliher Mike | See Remarks | A Award | 2025-02-25 | 2025-02-27 | 136,680 | — | $0 | 296,680 | SEC↗ |
| RAAB MICHAEL | President & CEO | A Award | 2025-02-25 | 2025-02-27 | 570,217 | — | $0 | 1,655,972 | SEC↗ |
| Renz Justin A | Chief Financial Officer | A Award | 2025-02-25 | 2025-02-27 | 136,680 | — | $0 | 422,648 | SEC↗ |
| Williams Laura A | Chief Medical Officer | A Award | 2025-02-25 | 2025-02-27 | 105,200 | — | $0 | 409,004 | SEC↗ |
| MOTT DAVID M | Director | P Buy | 2025-02-24 | 2025-02-26 | 77,729 | $5.00 | $388.6K | 2,015,494 | SEC↗ |
| GRAMMER ELIZABETH A | See Remarks | S Sale | 2025-02-20 | 2025-02-21 | 4,291 | $5.62 | $24.1K | 181,043 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2025-02-20 | 2025-02-21 | 22,964 | $5.62 | $129.1K | 1,085,755 | SEC↗ |
| Renz Justin A | Chief Financial Officer | S Sale | 2025-02-20 | 2025-02-21 | 5,171 | $5.62 | $29.1K | 285,968 | SEC↗ |
| Williams Laura A | Chief Medical Officer | S Sale | 2025-02-20 | 2025-02-21 | 4,941 | $5.62 | $27.8K | 303,804 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise deriv | 2025-01-31 | 2025-01-31 | 20,833 | — | $0 | 478,334 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise | 2025-01-31 | 2025-01-31 | 20,833 | $0.99 | $20.6K | 1,150,385 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2025-01-31 | 2025-01-31 | 41,666 | $5.36 | $223.3K | 1,108,719 | SEC↗ |
| MOTT DAVID M | Director | P Buy | 2025-01-21 | 2025-01-22 | 199,000 | $4.99 | $993.0K | 1,937,765 | SEC↗ |
| Rodgers Richard J | Director | M Exercise deriv | 2025-01-16 | 2025-01-17 | 100,000 | — | $0 | 0 | SEC↗ |
| Rodgers Richard J | Director | M Exercise | 2025-01-16 | 2025-01-17 | 100,000 | $0.55 | $55.0K | 350,524 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise deriv | 2025-01-07 | 2025-01-10 | 20,833 | — | $0 | 499,167 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise | 2025-01-07 | 2025-01-10 | 20,833 | $0.99 | $20.6K | 1,171,218 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2025-01-07 | 2025-01-10 | 41,666 | $5.31 | $221.2K | 1,129,552 | SEC↗ |
| MOTT DAVID M | Director | M Exercise deriv | 2024-12-26 | 2024-12-27 | 100,000 | — | $0 | 0 | SEC↗ |
| MOTT DAVID M | Director | M Exercise | 2024-12-26 | 2024-12-27 | 100,000 | $0.55 | $55.0K | 1,738,765 | SEC↗ |
| MOTT DAVID M | Director | P Buy | 2024-12-19 | 2024-12-23 | 213,300 | $4.67 | $996.1K | 1,638,765 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise deriv | 2024-12-10 | 2024-12-12 | 25,000 | — | $0 | 520,000 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise | 2024-12-10 | 2024-12-12 | 25,000 | $0.99 | $24.8K | 1,175,385 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2024-12-10 | 2024-12-12 | 25,000 | $5.26 | $131.5K | 1,150,385 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2024-11-25 | 2024-11-27 | 25,000 | $5.38 | $134.5K | 1,150,385 | SEC↗ |
| Blanks Robert | See Remarks | S Sale | 2024-11-20 | 2024-11-22 | 4,941 | $4.79 | $23.7K | 314,421 | SEC↗ |
| GRAMMER ELIZABETH A | See Remarks | S Sale | 2024-11-20 | 2024-11-22 | 7,046 | $4.79 | $33.8K | 185,334 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2024-11-20 | 2024-11-22 | 31,980 | $4.79 | $153.2K | 1,175,385 | SEC↗ |
| Renz Justin A | Chief Financial Officer | S Sale | 2024-11-20 | 2024-11-22 | 5,260 | $4.79 | $25.2K | 291,139 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | S Sale | 2024-11-20 | 2024-11-22 | 2,243 | $4.79 | $10.7K | 151,373 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | S Sale | 2024-11-20 | 2024-11-22 | 4,941 | $4.79 | $23.7K | 297,005 | SEC↗ |
| Williams Laura A | Chief Medical Officer | S Sale | 2024-11-20 | 2024-11-22 | 7,366 | $4.79 | $35.3K | 308,745 | SEC↗ |
| MOTT DAVID M | Director | P Buy | 2024-11-13 | 2024-11-14 | 215,868 | $4.62 | $997.3K | 1,425,465 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2024-11-11 | 2024-11-12 | 2,743 | $4.90 | $13.4K | 1,207,365 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | M Exercise deriv | 2024-11-06 | 2024-11-08 | 27,171 | — | $0 | 0 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | S Sale | 2024-11-06 | 2024-11-08 | 27,171 | $6.10 | $165.7K | 153,616 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | M Exercise | 2024-11-06 | 2024-11-08 | 27,171 | $2.32 | $63.0K | 180,787 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | M Exercise deriv | 2024-11-04 | 2024-11-06 | 27,172 | $2.32 | $63.0K | 27,171 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | M Exercise | 2024-11-04 | 2024-11-06 | 27,172 | $2.32 | $63.0K | 180,788 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | S Sale | 2024-11-04 | 2024-11-06 | 27,172 | $5.95 | $161.7K | 153,616 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise deriv | 2024-10-28 | 2024-10-31 | 25,000 | — | $0 | 545,000 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2024-10-28 | 2024-10-31 | 25,000 | $5.91 | $147.8K | 1,210,108 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise | 2024-10-28 | 2024-10-31 | 25,000 | $0.99 | $24.8K | 1,235,108 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2024-10-11 | 2024-10-15 | 7,500 | $6.01 | $45.1K | 1,210,108 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | S Sale | 2024-09-27 | 2024-10-01 | 49,564 | $6.92 | $343.0K | 301,946 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2024-09-26 | 2024-09-27 | 3,000 | $6.07 | $18.2K | 1,217,608 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | S Sale | 2024-09-13 | 2024-09-16 | 5,312 | $6.26 | $33.3K | 153,616 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise deriv | 2024-09-11 | 2024-09-13 | 35,000 | — | $0 | 570,000 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2024-09-11 | 2024-09-13 | 35,000 | $5.61 | $196.3K | 1,220,608 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise | 2024-09-11 | 2024-09-13 | 35,000 | $0.99 | $34.6K | 1,255,608 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2024-08-27 | 2024-08-28 | 7,500 | $6.22 | $46.6K | 1,219,509 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | M Exercise deriv | 2024-08-20 | 2024-08-20 | 20,507 | — | $0 | 49,806 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | M Exercise | 2024-08-20 | 2024-08-20 | 20,507 | $0.99 | $20.3K | 179,009 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | S Sale | 2024-08-20 | 2024-08-20 | 20,507 | $6.00 | $123.0K | 158,502 | SEC↗ |
| Blanks Robert | See Remarks | S Sale | 2024-08-20 | 2024-08-22 | 4,969 | $5.86 | $29.1K | 319,362 | SEC↗ |
| Felsch Robert Ora | See Remarks | S Sale | 2024-08-20 | 2024-08-22 | 3,567 | $5.86 | $20.9K | 91,560 | SEC↗ |
| GRAMMER ELIZABETH A | See Remarks | S Sale | 2024-08-20 | 2024-08-22 | 7,089 | $5.86 | $41.5K | 192,380 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2024-08-20 | 2024-08-22 | 32,225 | $5.86 | $188.8K | 1,227,009 | SEC↗ |
| Renz Justin A | Chief Financial Officer | S Sale | 2024-08-20 | 2024-08-22 | 5,289 | $5.86 | $31.0K | 295,257 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | S Sale | 2024-08-20 | 2024-08-22 | 2,250 | $5.86 | $13.2K | 156,252 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | S Sale | 2024-08-20 | 2024-08-22 | 4,969 | $5.86 | $29.1K | 351,510 | SEC↗ |
| Williams Laura A | Chief Medical Officer | S Sale | 2024-08-20 | 2024-08-22 | 7,412 | $5.86 | $43.4K | 314,740 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | S Sale | 2024-08-16 | 2024-08-20 | 20,000 | $5.94 | $118.8K | 356,479 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2024-08-12 | 2024-08-14 | 1,229 | $5.71 | $7.0K | 1,259,234 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | A Award deriv | 2024-08-08 | 2024-08-16 | 230,000 | — | $0 | 230,000 | SEC↗ |
| Foster Eric Duane | Chief Commercial Officer | A Award | 2024-08-08 | 2024-08-16 | 180,000 | — | $0 | 180,000 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise deriv | 2024-07-29 | 2024-07-31 | 30,000 | — | $0 | 605,000 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise | 2024-07-29 | 2024-07-31 | 30,000 | $0.99 | $29.7K | 1,290,463 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2024-07-29 | 2024-07-31 | 30,000 | $5.64 | $169.2K | 1,260,463 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2024-07-15 | 2024-07-17 | 7,500 | $5.97 | $44.8K | 1,260,463 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2024-06-28 | 2024-06-28 | 2,310 | $6.59 | $15.2K | 1,267,963 | SEC↗ |
| Blanks Robert | See Remarks | S Sale | 2024-06-21 | 2024-06-25 | 38,000 | $5.96 | $226.5K | 324,331 | SEC↗ |
| MOTT DAVID M | Director | A Award deriv | 2024-06-14 | 2024-06-17 | 40,243 | — | $0 | 40,243 | SEC↗ |
| Bazemore Robert B | Director | A Award deriv | 2024-06-14 | 2024-06-17 | 40,243 | — | $0 | 40,243 | SEC↗ |
| Cadoret-Manier Onaiza | Director | A Award deriv | 2024-06-14 | 2024-06-17 | 40,243 | — | $0 | 40,243 | SEC↗ |
| Bertrand William C JR | Director | A Award deriv | 2024-06-14 | 2024-06-17 | 40,243 | — | $0 | 40,243 | SEC↗ |
| Bhanji Muna | Director | A Award deriv | 2024-06-14 | 2024-06-17 | 40,243 | — | $0 | 40,243 | SEC↗ |
| Rodgers Richard J | Director | A Award deriv | 2024-06-14 | 2024-06-17 | 40,243 | — | $0 | 40,243 | SEC↗ |
| MOTT DAVID M | Director | A Award | 2024-06-14 | 2024-06-17 | 17,322 | — | $0 | 1,209,597 | SEC↗ |
| Bertrand William C JR | Director | A Award | 2024-06-14 | 2024-06-17 | 11,023 | — | $0 | 229,766 | SEC↗ |
| Rodgers Richard J | Director | A Award | 2024-06-14 | 2024-06-17 | 12,204 | — | $0 | 250,524 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise deriv | 2024-06-13 | 2024-06-17 | 35,000 | — | $0 | 665,000 | SEC↗ |
| RAAB MICHAEL | President & CEO | M Exercise | 2024-06-13 | 2024-06-17 | 35,000 | $0.99 | $34.6K | 1,305,273 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2024-06-13 | 2024-06-17 | 35,000 | $6.65 | $232.8K | 1,270,273 | SEC↗ |
| Williams Laura A | Chief Medical Officer | M Exercise deriv | 2024-06-05 | 2024-06-07 | 100,000 | — | $0 | 251,000 | SEC↗ |
| Williams Laura A | Chief Medical Officer | S Sale | 2024-06-05 | 2024-06-07 | 45,000 | $7.12 | $320.4K | 422,152 | SEC↗ |
| Williams Laura A | Chief Medical Officer | S Sale | 2024-06-05 | 2024-06-07 | 100,000 | $7.13 | $713.0K | 322,152 | SEC↗ |
| Williams Laura A | Chief Medical Officer | M Exercise | 2024-06-05 | 2024-06-07 | 100,000 | $2.75 | $275.0K | 467,152 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | S Sale | 2024-06-03 | 2024-06-05 | 17,872 | $7.00 | $125.1K | 158,502 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2024-05-29 | 2024-05-31 | 7,500 | $6.72 | $50.4K | 1,270,273 | SEC↗ |
| Blanks Robert | See Remarks | S Sale | 2024-05-21 | 2024-05-23 | 4,855 | $7.81 | $37.9K | 362,331 | SEC↗ |
| Felsch Robert Ora | See Remarks | S Sale | 2024-05-21 | 2024-05-23 | 3,485 | $7.81 | $27.2K | 95,127 | SEC↗ |
| GRAMMER ELIZABETH A | See Remarks | S Sale | 2024-05-21 | 2024-05-23 | 6,927 | $7.81 | $54.1K | 199,469 | SEC↗ |
| RAAB MICHAEL | President & CEO | S Sale | 2024-05-21 | 2024-05-23 | 31,484 | $7.81 | $245.9K | 1,277,773 | SEC↗ |
| Renz Justin A | Chief Financial Officer | S Sale | 2024-05-21 | 2024-05-23 | 5,167 | $7.81 | $40.4K | 300,546 | SEC↗ |
| Rodriguez Susan | Chief Commercial Officer | S Sale | 2024-05-21 | 2024-05-23 | 6,703 | $7.81 | $52.4K | 449,092 | SEC↗ |
| Rosenbaum David P. | Chief Development Officer | S Sale | 2024-05-21 | 2024-05-23 | 2,198 | $7.81 | $17.2K | 176,374 | SEC↗ |